The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array.

Alfredo Gonzalez-Sulser1, Jing Wang, Gholam K Motamedi

  • 1Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC, USA.

Neuropharmacology
|October 20, 2010
PubMed
Summary

The 4-aminopyridine (4-AP) epilepsy model reveals that glutamatergic and GABAergic signaling critically control epileptiform discharges. Blocking these pathways alters discharge initiation, propagation, and frequency in brain slices.

Related Concept Videos